-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 26/07/24 )
NAV
₹35.24
Last change
₹0.58 +0.02%
Fund Size (AUM)
4125.26 Cr
Performance
28.95% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 26/07/24
AUM
4125.26 Cr
Expense Ratio
1.95 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 51.95% | 17.99% | 28.95% |
| BSE Healthcare TR INR | 43.76% | 13.19% | 23.55% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
14.75% |
Dr Reddy's Laboratories Ltd |
7.79% |
Cipla Ltd |
7.16% |
Aurobindo Pharma Ltd |
6.51% |
Lupin Ltd |
6.01% |
Apollo Hospitals Enterprise Ltd |
4.77% |
Divi's Laboratories Ltd |
4.58% |
Gland Pharma Ltd |
3.64% |
Alkem Laboratories Ltd |
3.42% |
HealthCare Global Enterprises Ltd |
2.78% |
Sector Allocation
Healthcare |
92.13% |
Financial |
3.96% |
Basic Materials |
3.91% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
28.95% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.5% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
25.83% (5Y)
-
-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare-
Returns
-
25.83% (5Y)
-
